Equity Research Report
University of Memphis
Steward A Perry, MS

Executive Summary University of Memphis, Steward A Perry, MS Equity Research Report
Company: Pfizer, Inc.
Ticker: PFE
Price:$29.00 on 10/04/13 Recommendations:
Price Target One Year:

Trailing P/E Ratios = | Forward P/E Ratio = | PEG Ratio = .046 | Expected return for a Security = | Expected Risk for a security = |

Beta β = | Sharpe Ratio = | Treynor’s Reward to Volatility Ratio = |

Financial Summary * Expected Returns * Trailing P/E Ration * Forwarding P/E Ratio * Dividends Per Share * PEG Ratio * Market Capitalization * Growth in Revenues for the Last 12 Months

Risk Measurements * Beta β * Standard Deviation * Sharpe Ratio * Treynor’s Reward to Volatility Ratio Highlights Qualitative Analysis
Company Profile
Industry Overview
SWOT Analysis * Strengths * Weaknesses * Opportunities * Threats

Porter’s 5 Competitive Forces

I. The threat of substitute products

II. The threat of new competitors

III. The intensity of competitive rivalry

IV. The bargaining power of customers

V. The bargaining power of suppliers

Management

Financial Statement Analysis

Financial Ratio Analysis
The financial ratios in this report has been computed by using the income statements of Pfizer (PFE) during the fiscal year 2012. The income statements were obtained from the annual report submitted to the Security and Exchange Commission (SEC) website. This report will include the following ratios: Short-term solvency ratios, long-term solvency ratios, turnover ratios, profitability ratios, and market value ratios. These ratios will serve as a guide in determining the company’s position as it relates to performance for the present, and its performance as